RC
Repligen Corporation
🇩🇪XFRA.RGNGermanyHealthcare
€151.25EURup +7.65 (+5.33%)OpenEnd of day5:58 PM
Price€151.25+7.65 (+5.33%)
Profile
- Healthcare
- Medical Instruments & Supplies
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US7599161095
- CUSIP
- Not reported
Company
- Employees
- 2,000
- Headquarters
- Waltham, United States
- Website
- https://www.repligen.com
- CEO
- Mr. Olivier Loeillot
Market
- Shares outstanding
- 56.4M
- Market cap
- €8.54B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- €8.54B
- EPS LTM
- $0.73
- P/E LTM
- 186.11
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $785.1M+16.49%up year on year
- Net income
- $41.54M+400.42%up year on year
- Gross margin
- 51.05%+15.37%up year on year
- Free cash flow
- $110.78M+4.56%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.